Clot-busting drug shows hope

After eight years in the making, a new clot-busting drug is showing real promise as a safer and more effective alternative for treating heart attack and stroke.

While clot-busting or fibrinolytic drugs are hardly new, the researchers from Baker IDI are confident this novel fibrinolytic agent will overcome the current limitations in thrombolytic therapy associated with the risk of bleeding complications.

Led by Dr Christoph Hagemeyer, the